Gene Editing Provides Clues to Why Cancer Immunotherapy Often Fails

JAMA. 2017 Nov 7;318(17):1641-1642. doi: 10.1001/jama.2017.15507.
No abstract available

MeSH terms

  • CRISPR-Cas Systems
  • Gene Editing*
  • Humans
  • Immunotherapy*
  • Neoplasms / genetics*
  • Neoplasms / therapy
  • Treatment Failure